Startups Meet Pharma 2020 call is officially open!
The EIT Health Startups Meet Pharma is a challenge-based acceleration program connecting startups developing innovative solutions for chronic care with key pharma partners in Europe. The program invites startups developing solutions which impact both the Pharma industry and patients, to tackle set challenges in collaboration with top pharma partners.
The programs
The program targets start-ups with already functioning product / prototype that already entered the market / are about to enter the market. Selection of companies is based on the quality of the business idea, their fit for the selected challenge and the team’s motivation and level of commitment. Please note that only incorporated companies may apply to the program.
The selected startups will receive a grant to cover travel and accommodation costs and mentoring services through the Mentoring and Coaching Network Platform .
Challenges for 2020
In 2020, five challenges have been released in collaboration with four EIT Health Partners: Amgen, Bayer, Beiersdorf and Boehringer Ingelheim.
AMGEN
Challenge 1
Title: Encourage continuity in treatment strategy and treatment optimisation for post-myocardial infarction patients
Looking for: A solution which will create a standardised procedure for post MI patients after discharge
Challenge 2
Title: Choosing the right treatment for Multiple Myeloma patients
Looking for: Creation of an algorithm, that would help physicians choosing the right treatment for Multiple Myeloma patients
BAYER
Title: Disruptive Gene therapies, cell therapies and delivery technologies for different therapeutic areas
Looking for: Disruptive technologies useful in the therapeutic areas of Cardiology, Oncology, Gynecology, Ophthalmology, Hematology and Women’s Health – or ideally for all of those as a platform technology. Breakthrough innovations for other or multiple indications might be of interest as well.
BEIERSDORF
Title: Improving the condition of diabetic skin
Looking for: BioTech, MedTech or Digital Health solutions to improve the condition of diabetic skin
BOEHRINGER INGELHEIM
Title: Portable Interstitial Lung Disease (ILD) Diagnostic Tool
Looking for: A solution which could potentially help a wider range of Healthcare Professionals to early diagnose ILDs.
Deadline to apply: March 30.
All informations can be found here.